Trials / Completed
CompletedNCT02916017
HUMIRA® Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
HUMIRA® Special Investigation (Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 259 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 0 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the long- term safety and effectiveness of adalimumab in participants with non-infectious intermediate-, posterior-, or pan-uveitis in daily practice in Japan.
Conditions
Timeline
- Start date
- 2016-11-15
- Primary completion
- 2020-10-14
- Completion
- 2020-10-14
- First posted
- 2016-09-27
- Last updated
- 2021-10-14
Locations
39 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02916017. Inclusion in this directory is not an endorsement.